Production of purified polyhydroxyalkanoates (PHAs) for applications in contact with blood.
Samples of olyhydroxyalkanoates (PHAs), polyhydroxybutyrate (PHB) and copolymers poly(hydroxybutyrate-co-hydroxyvalerate) (PHBV) with 4 and 18 mol% hydroxyvalerate, synthesized by the bacteria Ralstonia eutropha B5786, were investigated. PHA films in contact with blood did not activate the hemostasis system at the level of cell response, but they did activate the coagulation system and the complement reaction. To detect biologically-active components in the PHAs, a detailed analysis of the composition of the polymers was conducted. Gas chromatography-mass spectrometry revealed long-chain fatty acids (FAs) in the tested PHAs. Their total concentration in the polymer ranged from tenths of mol% to 2-3 mol%, depending on the purification method. C16:0 constituted the largest proportion, up to 70%. Of the long-chain hydroxy acids, only beta-OH-C14:0 was detected and it did not exceed 0.06 mol%. The analysis of the hemocompatibility properties of the PHAs purified by a specialized procedure, including the quantitative and morphological estimation of platelets adherent to the surface of polymer films, the plasma recalcification time and complement activation studies, indicated that PHB and PHBV can be used in contact with blood. It has been found out that the lipopolysaccharides of bacteria producing PHAs, which contain mostly long-chain hydroxy acids, can be the factor activating the hemostasis systems. Thus, the technology of PHA purification must satisfy rather stringent specific requirements.
Sevastianov
V I
VI
Institute of Transplantology of Artificial Organs, Russian Ministry of Health, Shchukinskaya 1, 123182, Moscow, Russia.
Perova
N V
NV
Shishatskaya
E I
EI
Kalacheva
G S
GS
Volova
T G
TG
D001672:Biocompatible Materials / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology; D001769:Blood / Q000187:drug effects / Q000378:metabolism*; D001780:Blood Coagulation Tests / Q000379:methods; D002849:Chromatography, Gas; D003167:Complement Activation / Q000187:drug effects / Q000502:physiology; D020118:Cupriavidus necator / Q000254:growth & development / Q000378:metabolism*; D005227:Fatty Acids / Q000032:analysis / Q000737:chemistry; D006801:Humans; D010973:Platelet Adhesiveness / Q000187:drug effects / Q000502:physiology; D011091:Polyesters / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism* / Q000494:pharmacology*; D000091402:Prohibitins; D013499:Surface Properties
D001672:Biocompatible Materials; D005227:Fatty Acids; C000717328:PHB protein, human; D011091:Polyesters; D000091402:Prohibitins